Clinical Trials
Queen’s University leading cell therapy clinical trial to help improve outcomes in COVID-19 patients
Researchers at Queen’s University Belfast are leading a UK-wide clinical trial, offering an innovative cell therapy treatment for COVID-19 patients with acute respiratory failure.
This clinical trial, led by Professor Danny McAuley and Professor Cecilia O’Kane, both researchers from the...
Clinical Trials
Pfizer and BioNTech Aim to Start Testing Coronavirus Vaccines in Humans by Late April
Pfizer and BioNTech announced that they intend to advance multiple SARS-CoV-2 vaccine candidates into human clinical testing, with the first clinical trials potentially beginning by late April. The two companies began their collaboration focused on developing a vaccine for...
Clinical Trials
A World Pharma Today exclusive with Jim Murphy, CEO, Greenphire
Who would have thought a pandemic in this modern era would cripple the world, the strongest economies would be shaken, and end up being so vulnerable despite having the most modern technologies and processes at our disposal. That being...
Clinical Trials
Leading Life Sciences and Information Technology Companies Join EndPandemic National Data Consortium to Integrate COVID-19 Clinical Data
The EndPandemic National Data Consortium announced that it has received commitments from six leading life sciences and information technology companies to join the Consortium, the formation of which was announced on March 30, 2020. The companies will work together...
Clinical Trials
APEIRON Biologics InitiatesPhase II Clinical Trial of APN01 for Treatment of COVID-19
APEIRON Biologics AG announced that it has received regulatory approvals in Austria, Germany and Denmark to initiate a Phase II clinical trial of APN01 to treat COVID-19. APN01 is the recombinant form of the human angiotensin-converting enzyme 2 (rhACE2),...
Clinical Trials
Ergomed Announces Provision of Clinical Research Services for Second COVID-19
Ergomed plc , a company focused on providing specialised services to the pharmaceutical industry, announces it is providing support for a clinical development programme for namilumab, a monoclonal antibody therapy targeting granulocyte-macrophage colony stimulating factor (GM-CSF), for the treatment...
Clinical Trials
PHARMASEAL Supports Life Science Businesses by Offering No Cost CTMS for COVID-19 Clinical Trials
PHARMASEAL International, provider of clinical trials management systems has announced that it will offer the Engility® CTMS solution at no cost for COVID-19 Coronavirus clinical trials. The free offer to utilize Engility CTMS is open to biopharmaceutical organizations and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read